Ilona Dahmen

发表

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data

I. Petersen, S. Haas, M. Vingron, 2015, Genome Biology.

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

K. Cibulskis, J. Shendure, G. Getz, 2012, Nature Genetics.

A Genomics-Based Classification of Human Lung Tumors

G. Getz, S. Carter, D. Hayes, 2013, Science Translational Medicine.

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

Martin Vingron, Thomas Zander, Yupeng Cun, 2018, Nature Communications.

Comprehensive genomic profiles of small cell lung cancer

Martin Vingron, Jan O. Korbel, Lucia Anna Muscarella, 2015, Nature.

CD74-NRG1 fusions in lung adenocarcinoma.

I. Petersen, S. Haas, M. Vingron, 2014, Cancer discovery.

A tuft cell-like signature is highly prevalent in thymic squamous cell carcinoma and delineates new molecular subsets among the major lung cancer histotypes.

G. Ott, A. Marx, M. Kriegsmann, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data

I. Petersen, S. Haas, M. Vingron, 2015, Genome Biology.

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

I. Petersen, D. Hayes, M. Wilkerson, 2018, Nature Communications.

Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer

Roman K. Thomas, M. Peifer, J. Wolf, 2017, Clinical Cancer Research.

Frequent mutations in chromatin-remodeling genes in pulmonary carcinoids

Martin Vingron, Thomas Zander, Viktor Achter, 2014, Nature Communications.

Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

E. Smit, E. Felip, W. Engel-Riedel, 2018, Nature Communications.

iBRET Screen of the ABCD1 Peroxisomal Network and Mutation-Induced Network Perturbations.

R. Zimmer, C. Friedel, S. Gersting, 2021, Journal of proteome research.

Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer

Roman K. Thomas, M. Peifer, J. Wolf, 2017, Clinical Cancer Research.

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer

J. Minna, Roman K. Thomas, L. Girard, 2023, The Journal of clinical investigation.